Blueline Advisors’s Abbott ABT Stock Holding History

Blueline Advisors’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.54K	Hold	50	–	–	﹤0.01%	219
2026 Q1	$5.13K	Hold	50	–	–	﹤0.01%	179
2025 Q4	$6.26K	Buy	+50	New	+$6.37K	0.01%	175

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Blueline Advisors's ABT Position: Q2 2026 in Review

Blueline Advisors held its Abbott (ABT) position steady in Q2 2026 at 50 shares worth $4.54K. The position accounts for ﹤0.01% of the portfolio, ranked #219.

Blueline Advisors first reported a position in ABT in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.26K in Q4 2025. 2,961 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Blueline Advisors held 50 shares of Abbott worth $4.54K as of Q2 2026.
Blueline Advisors left its Abbott share count unchanged in Q2 2026.
Abbott made up ﹤0.01% of Blueline Advisors's portfolio in Q2 2026, its #219 holding.
Blueline Advisors first reported a position in Abbott in Q4 2025 and has held it in 3 quarters since.
Blueline Advisors's Abbott position peaked at $6.26K in Q4 2025.
2,961 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Blueline Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.